Gain Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6
Rok finansowy 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 100.4% -30.1% 471.3% -15.1% -60.6% -100.0%
Marża brutto 100.0% 100.0% -7722.5% -4242.1% 54.2% -45.7% 0.0%
EBIT (mln) -1 -2 -3 -14 -18 -22 -20
EBIT Δ r/r 0.0% 104.2% 65.7% 297.4% 28.6% 25.2% -8.5%
EBIT (%) -4989.7% -5084.9% -12047.5% -8379.8% -12688.1% -40328.3% nan
Koszty finansowe (mln) 0 0 0 0 -0 0 0
EBITDA (mln) -1 -2 -3 -14 -18 -22 -20
EBITDA(%) -4913.5% -4919.6% -11680.2% -8335.6% -12619.5% -40182.6% nan
Podatek (mln) 0 0 0 0 0 0 1
Zysk Netto (mln) -1 -2 -4 -14 -18 -22 -20
Zysk netto Δ r/r 0.0% 98.4% 63.1% 288.3% 26.6% 26.6% -8.3%
Zysk netto (%) -5364.4% -5310.9% -12387.7% -8418.9% -12555.1% -40354.3% nan
EPS -0.19 -0.18 -0.3 -1.37 -1.48 -1.71 -0.89
EPS (rozwodnione) -0.19 -0.18 -0.3 -1.37 -1.48 -1.71 -0.89
Ilośc akcji (mln) 6 12 12 10 12 13 23
Ważona ilośc akcji (mln) 6 12 12 10 12 13 23
Waluta USD USD USD USD USD USD USD